Stock Fundamentals

Company Information

Company Name
Briacell Therapeutics Corp
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: CA10778Y3023
CIK: 0001610820
CUSIP: 10778Y302
Currency: USD
Full Time Employees: 0
Phone: 604 921 1810
Fiscal Year End: July
IPO Date: Feb 24, 2021
Description:

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Address:

Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1

Directors & Officers

Name Title Year Born
Dr. William V. Williams FCPA, M.D. CEO, President & Director 1955
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. CFO & Corporate Secretary 1973
Dr. Miguel A. Lopez-Lago Ph.D. Chief Scientific Officer 1970
Dr. Giuseppe Del Priore M.D., M.P.H. Chief Medical Officer 1962
Dr. Charles Louis Wiseman FACP, M.D. Founder, Principal Research Advisor & Member of Scientific Advisory Board 1947

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 28, 2022 Jamieson Bondarenko N/A Purchase 186.00 $687.00 $127.78K
Dec 20, 2022 Jamieson Bondarenko N/A Purchase 146.00 $802.50 $117.17K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Sabby Management LLC 73.92K Mar 31, 2026 1.02% $0.69 0.00%
Iridian Asset Management LLC 65.00K Mar 31, 2026 0.90% $0.11 0.00%
LuminArx Capital Management LP 15.00K Mar 31, 2026 0.21% $0.05 0.00%
UBS Group AG 11.54K Mar 31, 2026 0.16% $0.00 1,708.93%
Morgan Stanley - Brokerage Accounts 3.02K Mar 31, 2026 0.04% $0.00 -13.71%
NATIONAL BANK OF CANADA /FI/ 802.00 Mar 31, 2026 0.01% $0.00 0.00%
Federation des caisses Desjardins du Quebec 455.00 Mar 31, 2026 0.01% $0.00 -62.24%
Hanson Mcclain Inc 100.00 Mar 31, 2026 0.00% $0.00 0.00%
Royal Bank of Canada 100.00 Mar 31, 2026 0.00% $0.00 0.00%
Group One Trading, LP 70.00 Dec 31, 2025 0.00% $0.00 0.00%
SSA SWISS ADVISORS AG 37.00 Dec 31, 2025 0.00% $0.00 0.00%
TD Waterhouse Canada Inc 19.00 Mar 31, 2026 0.00% $0.00 0.00%
HHM Wealth Advisors, LLC 6.00 Mar 31, 2026 0.00% $0.00 0.00%
Wells Fargo & Co 1.00 Mar 31, 2026 0.00% $0.00 0.00%
Tower Research Capital LLC 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
FLAGSHIP HARBOR ADVISORS, LLC 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Citadel Advisors Llc 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
SBI Securities Co Ltd 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
Advisor Group Holdings, Inc. 0.00 Dec 31, 2025 0.00% $0.00 -100.00%

Shares Statistics

Shares Outstanding: 7.25M
Shares Float: 6.41M
% Insiders: 50.70%
% Institutions: 533.30%
Short % Float: 6.49%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Nasdaq Composite Index 481.00 0.01% ▲ 0.00% Mar 31, 2025

Valuation Metrics

Enterprise Value: $-5.94M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $23.71M
EBITDA: $-30.63M
Book Value: $4.26
Earnings/Share: $-14.42
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -89.44%
ROE (TTM): -179.21%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-07-31 5.01x 0.00x 0.20x -735.69x 0.00x
2024-07-31 0.49x 0.00x 1.46x N/A 0.00x
2023-07-31 14.96x 0.00x 1.14x N/A 0.00x
2022-07-31 45.00x 0.00x 0.76x -15,761.80x 0.00x
2021-07-31 103.81x 0.00x 0.52x -86.96x 0.00x
2020-07-31 0.07x -0.11x 7.89x -108.81x -0.10x
2019-07-31 0.15x -0.47x 2.55x -198.70x -0.06x
2018-07-31 1.40x 1.19x 0.59x -244.39x -0.21x
2017-07-31 1.84x 0.00x 0.54x -623.36x 0.00x
2016-07-31 17.15x 0.00x 0.06x -604.80x 0.00x
2015-07-31 10.63x 0.00x 0.09x -264.37x 0.00x
2014-07-31 0.95x 0.00x 1.05x -39.72x 0.00x
2013-07-31 19.91x 0.00x 0.01x -17.17x 0.00x
2012-07-31 7.51x 0.00x 0.03x -14.72x 0.00x
2011-07-31 7.25x 0.00x 0.06x -75.03x 0.00x
2010-07-31 47.30x 0.00x 0.02x -115.29x 0.00x
2009-07-31 12.01x 0.00x 0.06x -92.13x 0.00x
2008-07-31 22.76x 0.00x 0.04x N/A 0.00x
2007-07-31 47.61x 0.00x 0.02x N/A 0.00x
2006-07-31 5.35x 0.00x 0.17x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BCTX.US!